Bacterial vaginosis (BV) is a common vaginal infection.Is one of the most widely studied obstetric/gynecological infectious diseases.An infection associated with a group of pathogenic anaerobic microorganisms rather than a specific pathogen.This includes surgery and medication.Bacterial vaginosis is treated with oral and local treatment by detecting odor, clue cells and alkalinity of secretions.
This report contains market size and forecasts of Bacterial Vaginosis Treatment in Global, including the following market information:
Global Bacterial Vaginosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bacterial Vaginosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bacterial Vaginosis Treatment include Bayer, Pfizer, Lupin Inc, Merck, Sanofi, Piramal, Abbott, Galderma and Mission, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bacterial Vaginosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacterial Vaginosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bacterial Vaginosis Treatment Market Segment Percentages, by Type, 2021 (%)
Surgical Treatment
Drug Treatment
Global Bacterial Vaginosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bacterial Vaginosis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialist Treatment Centre
Other
Global Bacterial Vaginosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bacterial Vaginosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bacterial Vaginosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bacterial Vaginosis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Pfizer
Lupin Inc
Merck
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge